Anavex Life Sciences Corp (AVXL)

[abew4me]

Let's keep things in perspective.

1) The entire stock market has taken a huge dive...not just AVXL.

2) Anavex is announcing its fiscal results for the 1st quarter this Wednesday...followed by a CC. IR stated that they will be laying out a detailed plan going forward.

3) All of the naysayers that reject a submission for a NDA using the trial results from Avatar DO NOT have all of the information that the company has. It is pure speculation on their part.

4) Anavex can also file for approval with Australia's TGA and the U.K.'s health department...which could put additional pressure on the FDA by the Rett Syndrome community. (Don't underestimate their voice!)

5) Whether you believe that Anavex will file for a NDA or not, doesn't change the success that the P3 Rett trial accomplished by proving our Mechanism of Action (MOA) for A2-73.

6) Having a proven MOA now increases the success of our P2b/3 Alzheimer's Disease trial that should have TLR by September/October of this year. (And frankly, this is why I originally invested in Anavex in the first place)

Lastly, I never saw Too-Tall-Jones throw in the towel before the game was over. (Say it aint so, Ed!) LOL

In all seriousness, you should remember that the FDA has a wide range of flexibility to approve the results from the Avatar trial by itself. With an extremely impressive 7-year safety record, the FDA has to weigh the benefits vs. the negatives(?) of approving A2-73 for the Adult Rett population.

We should know more after the CC this Wednesday.